Skip to content

Clinical trials

Bronchiolitis Obliterans Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Country / region: Germany Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20064
20071
20081
20094
20102
20117
20121
20133
20144
20155
20165
20173
20183
20192
20204
20212
20231
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated11
Recruiting7
Active, not recruiting5
Unknown status5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Incyte Corporation7
Pfizer6
AstraZeneca3
Gilead Sciences3
Charite University, Berlin, Germany2
MetrioPharm AG2
Pharmacyclics LLC.2
Sanofi2
Zambon SpA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome62
Graft vs Host Disease6
Lymphoma, Follicular6
Psoriasis6
Leukemia5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Hepatitis C3
Low Back Pain3
Pain3
Pruritus3

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.